ICU Medical (ICUI) Sets New 12-Month High and Low at $307.92

ICU Medical, Incorporated (NASDAQ:ICUI)’s share price hit a new 52-week high and low during trading on Thursday . The company traded as low as $307.92 and last traded at $306.45, with a volume of 1947 shares traded. The stock had previously closed at $306.10.

A number of brokerages have recently commented on ICUI. Zacks Investment Research raised ICU Medical from a “hold” rating to a “strong-buy” rating and set a $311.00 price objective for the company in a research report on Wednesday, May 16th. TheStreet downgraded ICU Medical from an “a” rating to a “c+” rating in a report on Wednesday, May 9th. ValuEngine raised ICU Medical from a “buy” rating to a “strong-buy” rating in a report on Saturday, June 2nd. Finally, BidaskClub raised ICU Medical from a “buy” rating to a “strong-buy” rating in a report on Saturday, April 28th. One analyst has rated the stock with a hold rating, one has assigned a buy rating and three have assigned a strong buy rating to the stock. ICU Medical currently has a consensus rating of “Buy” and an average target price of $311.00.

The firm has a market cap of $5.90 billion, a PE ratio of 56.07 and a beta of 0.36.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings results on Wednesday, May 9th. The medical instruments supplier reported $2.26 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.84 by $0.42. The firm had revenue of $372.00 million during the quarter, compared to the consensus estimate of $346.28 million. ICU Medical had a return on equity of 9.55% and a net margin of 1.25%. The firm’s quarterly revenue was up 50.2% compared to the same quarter last year. During the same period in the prior year, the company posted $1.68 earnings per share. research analysts anticipate that ICU Medical, Incorporated will post 6.66 EPS for the current fiscal year.

In related news, Director George A. Lopez sold 13,443 shares of the company’s stock in a transaction that occurred on Monday, March 19th. The stock was sold at an average price of $249.66, for a total value of $3,356,179.38. Following the completion of the transaction, the director now directly owns 526,574 shares of the company’s stock, valued at $131,464,464.84. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Robert S. Swinney sold 343 shares of the company’s stock in a transaction that occurred on Monday, June 11th. The shares were sold at an average price of $290.95, for a total value of $99,795.85. Following the completion of the transaction, the director now directly owns 18,383 shares of the company’s stock, valued at $5,348,533.85. The disclosure for this sale can be found here. Insiders sold 148,886 shares of company stock valued at $39,614,760 over the last ninety days. 12.50% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of ICUI. Israel Discount Bank of New York lifted its stake in ICU Medical by 74.8% in the fourth quarter. Israel Discount Bank of New York now owns 853 shares of the medical instruments supplier’s stock valued at $184,000 after buying an additional 365 shares during the last quarter. First Republic Investment Management Inc. purchased a new stake in ICU Medical in the fourth quarter valued at approximately $200,000. Zeke Capital Advisors LLC purchased a new stake in ICU Medical in the first quarter valued at approximately $200,000. Eagle Boston Investment Management Inc. purchased a new stake in ICU Medical in the first quarter valued at approximately $206,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in ICU Medical by 39.2% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 984 shares of the medical instruments supplier’s stock valued at $213,000 after buying an additional 277 shares during the last quarter. Institutional investors own 72.23% of the company’s stock.

About ICU Medical

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply